Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001786785 | SCV002028723 | uncertain significance | not provided | 2021-11-23 | criteria provided, single submitter | clinical testing | Identified in the heterozygous state in a male with congenital hypogonadotropic hypogonadism and in two females with polycystic ovarian syndrome (Gorsic et al., 2019; Malone et al., 2019); Published functional studies suggest a damaging effect on AMH activity, AMH protein secretion, and downstream signaling (Gorsic et al., 2019; Malone et al., 2019); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 28505284, 31291191, 30786001) |
Labcorp Genetics |
RCV001786785 | SCV002151336 | uncertain significance | not provided | 2024-10-17 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with serine, which is neutral and polar, at codon 99 of the AMH protein (p.Thr99Ser). This variant is present in population databases (rs200226465, gnomAD 0.04%). This missense change has been observed in individual(s) with hypogonadotropic hypogonadism (PMID: 31291191). ClinVar contains an entry for this variant (Variation ID: 1326605). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects AMH function (PMID: 30786001, 31291191). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002478018 | SCV002788473 | uncertain significance | Persistent Mullerian duct syndrome | 2021-12-20 | criteria provided, single submitter | clinical testing |